Chapter 11. Peroxisome Proliferator-Activated Receptor γ Modulation for the Treatment of Type 2 Diabetes
- Prof. Dr. Eckhard Ottow3,
- Dr. Hilmar Weinmann4
Published Online: 19 DEC 2008
DOI: 10.1002/9783527623297.ch11
Copyright © 2008 Wiley-VCH Verlag GmbH & Co. KGaA
Book Title

Nuclear Receptors as Drug Targets
Additional Information
How to Cite
Warshawsky, A. M. and Miller, A. R. (2008) Peroxisome Proliferator-Activated Receptor γ Modulation for the Treatment of Type 2 Diabetes, in Nuclear Receptors as Drug Targets (eds E. Ottow and H. Weinmann), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527623297.ch11
Editor Information
- 3
Bayer Schering Pharma AG, Medicinal Chemistry (S106/345), Müllerstrasse 178, 13342 Berlin, Germany
- 4
Bayer Schering Pharma AG, Medicinal Chemistry (S106/048A), Müllerstrasse 178, 13342 Berlin, Germany
Publication History
- Published Online: 19 DEC 2008
- Published Print: 20 AUG 2008
Book Series:
Book Series Editors:
- Prof. Dr. Raimund Mannhold5,
- Prof. Dr. Hugo Kubinyi6,
- Prof. Dr. Gerd Folkers7
Series Editor Information
- 5
Molecular Drug Research Group, Heinrich-Heine-Universität, Universitätsstrasse 1, 40225 Düsseldorf, Germany
- 6
Donnersbergerstrasse 9, 67256 Weisenheim am Sand, Germany
- 7
Collegium Helveticum, STW/ETH Zurich, 8092 Zurich, Switzerland
ISBN Information
Print ISBN: 9783527318728
Online ISBN: 9783527623297
- Summary
- Chapter
- References
Keywords:
- peroxisome proliferator-activated receptor γ;
- type 2 diabetes
Summary
This chapter contains sections titled:
Introduction
Currently Marketed PPARγ Ligands
Approaches to Improve PPARγ Activity
Discussion and Summary
Future Direction
References
